In addition to this, S100A8 and S100A9 transcripts were able to discriminate mesenchymal group from other GBM subtypes with an AUC of 0.75 and 0.75 respectively (p < 0.0001, p < 0.0001, Fig. 5C). The gene discussed is S100A9; the disease is glioblastoma.